Back
Marker Therapeutics Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
26
MRKR
Marker Therapeutics
Last Price:
2.81
Seasonality Move:
-21.54%
7 Day Trial
ALL ACCESS PASS
$
7
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHT- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.84 | Sell |
| 20-day SMA: | 3.23 | Sell |
| 50-day SMA: | 4.06 | Sell |
| 200-day SMA: | 4.23 | Sell |
| 8-day EMA: | 2.88 | Sell |
| 20-day EMA: | 3.18 | Sell |
| 50-day EMA: | 3.7 | Sell |
| 200-day EMA: | 4.08 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 34.94 | Sell |
| Chaikin Money Flow: | -22774 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.91 - 3.61) | Sell |
| Bollinger Bands (100): | (3.4 - 4.9) | Sell |
Marker Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.79 while MRKR 8-day simple moving average is 2.84, which is a Sell signal.
- The stock price of MRKR is 2.79 while Marker Therapeutics 20-day SMA is 3.23, which makes it a Sell.
- Marker Therapeutics 50-day simple moving average is 4.06 while MRKR share price is 2.79, making it a Sell technically.
- MRKR stock price is 2.79 and Marker Therapeutics 200-day simple moving average is 4.23, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a Sell
The current Marker Therapeutics [MRKR] share price is $2.79. The Score for MRKR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
24.89M
Price in USD:
2.79
Share Volume:
33.49K
Marker Therapeutics 52-Week Range
52-Week High:
6.16
52-Week Low:
2.40
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?
The Marker Therapeutics stock price is 2.79 USD today. -
Will MRKR stock go up or go down?
Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Marker Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.79 while MRKR 8-day exponential moving average is 2.88, which is a Sell signal.
- The stock price of MRKR is 2.79 while Marker Therapeutics 20-day EMA is 3.18, which makes it a Sell.
- Marker Therapeutics 50-day exponential moving average is 3.70 while MRKR share price is 2.79, making it a Sell technically.
- MRKR stock price is 2.79 and Marker Therapeutics 200-day simple moving average is 4.08, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
- MRKR Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Marker Therapeutics is a Sell
- Marker Therapeutics Relative Strength Index (RSI) is 34.94, which suggest Marker Therapeutics is oversold
- The Bollinger Bands (25) for Marker Therapeutics is (2.91 - 3.61), which suggest Marker Therapeutics is a Sell
- The Bollinger Bands (100) for Marker Therapeutics is (3.4 - 4.9), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.